Account

Table 6 Review of the literature regarding PR concordance

From: Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature

	No of samples	Concordance (%)	IHC clone
Badoual, 2005 [25]	103	89.3	PR10A9, Immunotech
Burge, 2006 [26]	87	89	PgR 636, Dako
Wood, 2007 [28]	100	90.3	PgR 636, Dako
Arnedos, 2009 [29]	336	85	1E2, Ventana
Tamaki, 2010 [30]	353	89.5	6, Ventana
Uy, 2010§ [31]	160	85.6	PgR 636, Dako
Lorgis, 2011° [32]	175	78.3	PgR 636, Dako
Ough, 2011 [33]	209	78	Not reported
Li, 2012# [34]	2448	84.8
Seferina, 2012° [35]	526	83.6	PgR 636, Dako
Greer, 2013 [37]	205	89	PgR 1294, Dako PgR 636, Dako
Motamedolshariati, 2014 [39]	30	90	Not reported
Chen, 2017 [40]	985	73.5	1E2, Ventana
Ensani, 2017 [41]	100	81	PR88, Biogenex
Kombak, 2017 [42]	284	89.4	16, Leica
Meattini, 2017° [43]	101	88.1	16, Ventana
You, 2017§ [44]	1219	95	16, Novocastra
Berghuis, 2019 [45]	890	84.8	Multiple
Jeong, 2020§ [46]	623	93	1E2, Ventana
Shanmugalingam, 2022 [47]	484	93.2	IE2, Ventana
Slostad, 2022 [48]	961	87.2	LDT

# meta-analysis, ° positivity threshold: 10%, § Allred score, IHC immunohistochemistry, LDT laboratory-developed test

Back to article page